Fig. 9From: Syringin exerts anti-breast cancer effects through PI3K-AKT and EGFR-RAS-RAF pathwaysThe expression of PIK3CA and HRAS by Real-Time PCR. A Syringin decreased their expression in MCF-7 cells. B Syringin decreased their expression in MDA-MB-231 cells. *P < 0.05 and **P < 0.01. C The expression of PIK3CA in normal breast and BC tissues. D The expression of HRAS in normal breast and BC tissuesBack to article page